(Q44340437)

2 December 2017

Relation of diabetic macular edema to cytokines and posterior vitreous detachment (English)

1 reference

2 December 2017

diabetic macular edema

1 reference

Hideharu Funatsu

1

1 reference

2 December 2017

Hidetoshi Yamashita

2

1 reference

2 December 2017

Tomohiro Ikeda

3

1 reference

2 December 2017

Tatsuya Mimura

4

1 reference

2 December 2017

Erika Shimizu

5

1 reference

2 December 2017

Sadao Hori

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

American Journal of Ophthalmology

2 December 2017

1 reference

2 December 2017

135

1 reference

2 December 2017

3

1 reference

2 December 2017

321-327

1 reference

Diabetic macular edema. A review

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

The pathogenesis of edema in diabetic maculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Modulation of the renin-angiotensin system and retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

The role of the vitreous in diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Tomographic assessment of vitreous surgery for diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Vitrectomy for diffuse macular edema in cases of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901971-2

10.1016/S0002-9394(02)01971-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference